Summary Slide | Evinacumab for Refractory Hypercholesterolemia
Image Modality: Illustration Table Figure
Description: Summary Slide | Evinacumab for Refractory Hypercholesterolemia
Date: March 26, 2021
Keywords: AHA Annual Scientific Sessions, AHA20 Slides, Antibodies, Monoclonal, Apolipoproteins B, Atherosclerosis, Cholesterol, LDL, Dyslipidemias, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypercholesterolemia, Hyperlipoproteinemia Type II, Nasopharyngitis, PCSK9 protein, human, Primary Prevention, Proprotein Convertase 9, Triglycerides